InvestorsHub Logo
Followers 120
Posts 20756
Boards Moderated 0
Alias Born 06/13/2011

Re: alternatepatel post# 49037

Friday, 05/08/2015 11:08:12 AM

Friday, May 08, 2015 11:08:12 AM

Post# of 426489
Alt and Biowreck ...my quick take

1) 1st Amendment issue has wide implications ...far beyond Amarins own situation ( ie no deal/compromise with FDA was possible Alt ) because as we stand now Dietary Supplements sellers are allowed greater lee way on what they can put on packages ( studies show O3's are heart healthy etc )

2)CEO knew market would not like the earnings miss. You are looking at a loss of $30m ? with $168m ? in cash on hand .
A cash burn of $30m a qt gets you in a tight position mid 2016 ...if that continues
So the critical side of me says " Hey good time to deflect attention and announce our law suit 1 day before CC "

3) CEO acknowledges that some changes in end of year coverage plan may have made Vascepa more expensive for some ...well people on this board have complained about higher co pays ....and the current coupon plan ends end of 2015

4) KOWA effect ?

This all rides on an early stop for RI IMHO
Sorry if this sounds negative ...just my take on the recent events
Kiwi
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News